Osmotica Pharmaceuticals PLCOsmotica Pharmaceuticals PLC - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

If you are employed by Osmotica Pharmaceuticals PLC and you would like to licence your Sustainability rating, please contact us. Complete ESG assessment of Osmotica Pharmaceuticals PLC are reached by logging in. This Sustainability rating for Osmotica Pharmaceuticals PLC represents the company's reporting of the United Nations Sustainable Development Goals.

Osmotica Pharmaceuticals PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.8; made up of an environmental score of 2.0, social score of 2.7 and governance score of 3.4.

SDG Transparency Score for Osmotica Pharmaceuticals PLC 

2.8

Low Impact
0 - 3
Medium
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Osmotica Pharmaceuticals PLC 
2.0

Environmental

2.7

Social

3.4

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
.........
1836Vanta Bioscience Ltd
2.9
Medium
1836Zhejiang Orient Gene Biotech Co Ltd
2.9
Medium
1874Osmotica Pharmaceuticals PLC
2.8
Medium
1874Aeterna Zentaris Inc
2.8
Medium
1874Anhui Anke Biotechnology Group Co Ltd
2.8
Medium
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Osmotica Pharmaceuticals PLC have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC report the average age of the workforce?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC disclose cybersecurity risks?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC offer flexible work?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC conduct supply chain audits?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC disclose water use targets?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Osmotica Pharmaceuticals PLC have a product recall in the last two years?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC disclose incidents of discrimination?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Osmotica Pharmaceuticals PLC issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC disclose parental leave metrics?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Osmotica Pharmaceuticals PLC involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC disclose its waste policy?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC report according to TCFD requirements?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC disclose energy use targets?

LockedSign up for free to unlock

Does Osmotica Pharmaceuticals PLC disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Osmotica Pharmaceuticals PLC have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Osmotica Pharmaceuticals PLC
These potential risks are based on the size, segment and geographies of the company.

Osmotica Pharmaceuticals plc, an integrated biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products in the United States, Argentina, and Hungary. The company's promoted products include M-72, a methylphenidate hydrochloride extended-release tablet to treat attention deficit hyperactivity disorder (ADHD); Osmolex ER, an amantadine extended-release tablet for the treatment of Parkinson's disease and drug-induced extrapyramidal reactions in adults; Arbaclofen extended-release tablets which is in phase III clinical trial for the treatment of multiple sclerosis spasticity; Upneeq, an oxymetazoline hydrochloride ophthalmic solution for the treatment of Blepharoptosis; and OS870 which is in Phase I clinical trial for the treatment of neurodegenerative disorders. It also provides women's health products, including Divigel for menopause; and OB Complete, a dietary supplement for prenatal, pregnancy, and postnatal periods. In addition, the company's non-promoted products comprise methylphenidate ER tablets for ADHD; venlafaxine ER tablets to treat major depressive disorders and social anxiety disorders; hydromorphone ER for treating pain; nifedipine ER for hypertension; sodium benzoate/sodium phenylacetate for the treatment of hyperammonemia; oxybutynin ER for overactive bladder; prescription prenatal vitamins for treating nutritional requirements during pregnancy; Lorzone, an immediate-release form of chlorzoxazone indicated for the treatment of acute musculoskeletal pain in conjunction with rest and physical therapy; ConZip, a tramadol hydrochloride for the management of pain; and nitrofurantoin for the treatment of urinary tract infections, as well as Osmodex and other abbreviated new drug applications. Osmotica Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.

Sorry!

Failed to process!